世界の感染症診断市場の規模、シェア、COVID-19の影響分析、製品別(機器、試薬、キット、消耗品、サービス)、技術別(臨床微生物学、ポリメラーゼ連鎖反応、in situハイブリダイゼーション、等温核酸増幅技術、免疫診断、その他)、用途別(COVID-19、消化管感染症、呼吸器疾患、性感染症、結核、院内感染、蚊媒介性疾患、その他)、最終用途別(病院、診療所、診断研究所、研究機関、その他)、地域別(北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ)、2022年～2032年の分析と予測。

世界の感染症診断市場 規模は2032年までに380.2億米ドルに達すると予想されます。

Spherical Insights & Consultingが発行した調査レポートによると、世界の感染症診断市場規模は、予測期間中に5.4%の複合年間成長率(CAGR)で成長し、2022年の224.7億米ドルから2032年には380.2億米ドルに達すると予想されています。

 「世界の感染症診断市場の 規模、シェア、COVID-19の影響分析、製品別(機器、試薬、キット、消耗品、サービス)、技術別(臨床微生物学、ポリメラーゼ連鎖反応、in situハイブリダイゼーション、等温核酸増幅技術、免疫診断、その他)、アプリケーション別(COVID-19、消化管感染症、呼吸器疾患、性感染症、結核、院内感染、蚊媒介性疾患、その他)、最終用途別(病院、診療所、診断研究所、研究機関、その他)、地域別(北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ)のレポートから、110の市場データ表と図表を含む233ページにわたる主要な業界の洞察を参照してください。2022年の分析と予測- 2032年。

Infectious disease diagnostics involve techniques to detect pathogens like bacteria, viruses, fungi, and parasites. Molecular methods like PCR and sequencing rapidly identify genetic material, while serological assays measure antibodies for exposure and immunity. Immunological approaches detect antigens or use cultures to pinpoint agents. These diagnostics enable early detection, treatment, and containment of infections, playing a vital role in public health and patient care.

In 2022, the reagents, kits & consumables segment accounted for around 42.8% market share

On the basis of the product, the global infectious disease diagnostics market is segmented into instruments, reagents, kits & consumables, and services. The reagents, kits, and consumables segment has emerged as the dominant force in the infectious disease diagnostics market due to its essential role in facilitating diagnostic procedures. These components form the backbone of diagnostic tests, enabling accurate pathogen detection and characterization. With consistent demand for diagnostic assays, this segment has experienced robust growth. The reliance on standardized reagents, user-friendly kits, and reliable consumables underscores their critical importance in ensuring consistent and reproducible results.

The immunodiagnostics segment held the largest market with more than 38.5% revenue share in 2022

Based on the technology, the global infectious disease diagnostics market is segmented into clinical microbiology, polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, immunodiagnostics, and others. The immunodiagnostics segment has captured the largest market share in infectious disease diagnostics due to its pivotal role in detecting infections. Utilizing the immune response, immunodiagnostics offer a diverse range of tests, including serological assays and antigen detection methods, enabling accurate identification of various pathogens. This segment's widespread adoption is driven by its high sensitivity, specificity, and versatility, making it a cornerstone in infectious disease detection.

Respiratory diseases segment is expected to grow at the fastest CAGR of around 5.7% during the forecast period

Based on the application, the global infectious disease diagnostics market is segmented into COVID-19, gastrointestinal tract infections, respiratory diseases, sexually transmitted infections, tuberculosis, hospital-acquired infection, mosquito-borne diseases, and others. The respiratory diseases segment is poised for rapid growth during the forecast period due to the increasing prevalence of respiratory infections, coupled with the ongoing COVID-19 pandemic, has heightened the demand for accurate and timely diagnostic solutions. Early detection of respiratory pathogens is crucial for effective disease management and containment. Advances in molecular and point-of-care testing have enhanced the speed and accuracy of respiratory disease diagnostics.

The hospitals segment held the largest market over the forecast period

Based on the end-use, the global Infectious disease diagnostics market is segmented into hospitals, clinics, diagnostics laboratories, research institutes, and others. The hospitals segment has dominated the infectious disease diagnostics market over the forecast period due to its pivotal role as a primary point of patient care and disease management. Hospitals offer comprehensive diagnostic services, equipped with advanced technologies and expert medical professionals, making them central hubs for infectious disease testing.

Asia-Pacific is predicted to grow at a higher CAGR of around 5.6% over the projected period.

Based on region, Asia-Pacific is poised for substantial growth in the infectious disease diagnostics market during the forecast period due to factors such as rising population, increasing healthcare investments, and improving healthcare infrastructure. The region's susceptibility to infectious diseases, coupled with the growing demand for rapid and accurate diagnostics, is driving market expansion.

North America commands the infectious disease diagnostics market due to its robust healthcare infrastructure, advanced research capabilities, and high healthcare expenditure. The region's early adoption of innovative diagnostic technologies, coupled with a proactive approach to disease surveillance and control, has solidified its dominance.

Some of the major players in the global infectious disease diagnostics market include Abbott Laboratories, BioMerieus SA, Becton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, F Hoffman-La Roche, Hologic Inc., Qiagen Inc., Siemens Healthineers, and Thermo Fisher Scientific Inc.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global infectious disease diagnostics market based on the below-mentioned segments:

Infectious Disease Diagnostics Market, By Product

• Instruments
• Reagents, kits & consumables
• Services

Infectious Disease Diagnostics Market, By Technology

• Clinical Microbiology
• Polymerase chain reaction
• In Situ Hybridization
• Isothermal Nucleic Acid Amplification Technology
• 免疫診断
• その他

感染症診断市場、用途別

• COVID-19(新型コロナウイルス感染症
• 消化管感染症
• 呼吸器疾患
• 性感染症
• 結核
• 院内感染
• 蚊媒介性疾患
• その他

感染症診断市場、最終用途別

• 病院
• クリニック
• 診断研究所
• 研究機関
• その他

感染症診断市場、地域分析

• 北米
  • 私たち
  • カナダ
  • メキシコ
• ヨーロッパ
  • ドイツ
  • イギリス
  • フランス
  • イタリア
  • スペイン
  • ロシア
  • その他のヨーロッパ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他のアジア太平洋地域
• 南アメリカ
  • ブラジル
  • アルゼンチン
  • 南米のその他の地域
• 中東・アフリカ
  • アラブ首長国連邦
  • サウジアラビア
  • カタール
  • 南アフリカ
  • その他の中東およびアフリカ